DESTONEE WILSON: Open Payments
NPI 1174041578 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,048 in 56 payments from 16 companies in 2025. Trend: 2023 $1,586 · 2024 $1,325 · 2025 $1,048
Food & beverage: $1,048
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 24 | $458 |
| Lilly USA, LLC | 6 | $107 |
| ABBVIE INC. | 4 | $84 |
| AstraZeneca Pharmaceuticals LP | 4 | $63 |
| ALK-Abello, Inc | 2 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $48 |
| Xeris Pharmaceuticals, Inc. | 2 | $42 |
| Exact Sciences Corporation | 2 | $39 |
| PFIZER INC. | 2 | $37 |
| Axsome Therapeutics, Inc. | 1 | $22 |
Products named: Rybelsus, Wegovy, MOUNJARO, Ozempic, UBRELVY, Grastek, Kerendia, KEVEYIS.
Industry payments across TX — which companies pay providers there.
